Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Next generation live-attenuated yellow fever vaccine candidate: Safety and immuno-efficacy in small animal models

1 Mar 2021

Abstract excerpt

Yellow fever (YF) remains a threat to human health in tropical regions of Africa and South America. Live-attenuated YF-17D vaccines have proven to be safe and effective in protecting travellers and populations in endemic regions against YF, despite very rare severe reactions following vaccination - YF vaccine-associated viscerotropic disease (YEL-AVD) and neurological disease (YEL-AND). We describe the generation...

Topics

Join the communities discussing this publication.

Mosquito-borne diseases and control
Vibrio bacteria research studies
Viral Infections and Outbreaks Research

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 33685778
DOI: 10.1016/j.vaccine.2021.02.033

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Next generation live-attenuated yellow fever vaccine candidate: Safety and immuno-efficacy in small animal modelsPMID 33685778Read ↗

Phenotypic and genetic characterization of a next generation live-attenuated yellow fever vaccine candidate.Semantic proximity Read ↗

Molecular characterization of the 17D-204 yellow fever vaccine.Semantic proximity Read ↗

Yellow Fever: Integrating Current Knowledge with Technological Innovations to Identify Strategies for Controlling a Re-Emerging VirusSemantic proximity Read ↗

The yellow fever 17D virus as a platform for new live attenuated vaccinesSemantic proximity Read ↗

A DNA Vaccine against Yellow Fever Virus: Development and EvaluationSemantic proximity Read ↗

Phenotypic and molecular analyses of yellow fever 17DD vaccine viruses associated with serious adverse events in Brazil.Semantic proximity Read ↗

Two mutations in NS2B are responsible for attenuation of the yellow fever virus (YFV) vaccine strain 17D.Semantic proximity Read ↗

The 17D-204 and 17DD yellow fever vaccines: an overview of major similarities and subtle differencesSemantic proximity Read ↗

Production of yellow fever 17DD vaccine virus in primary culture of chicken embryo fibroblasts: yields, thermo and genetic stability, attenuation and immunogenicity.Semantic proximity Read ↗

Characterization of a viscerotropic yellow fever vaccine variant from a patient in Brazil.Semantic proximity Read ↗

Antigenic variants of yellow fever virus with an altered neurovirulence phenotype in mice.Semantic proximity Read ↗

Comparison of the genomes of the wild-type French viscerotropic strain of yellow fever virus with its vaccine derivative French neurotropic vaccineSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.